. Bile acids were perfused at an amount of 30 or 100% as determined on day 1 in combination with the test meal in the presence or absence of loxiglumide. Pancreatic enzymes, bilirubin, and bile acid output were determined in duodenal juice. Plasma cholecystokinin (CCK) and plasma pancreatic polypeptide (PP) were measured radioimmunologically. Results-Bile acid perfusion did not significantly alter stimulated pancreatic enzyme, bilirubin or bile acid output or plasma CCK. Loxiglumide did not alter basal CCK release but increased test meal stimulated CCK output fourfold (p<0.05). The addition of bile acids to the test meal at a dose resembling 30% of bile acid output as determined on day 1 prevented this increase. Plasma PP concentration remained unchanged by bile acids and were mostly undetectable during loxiglumide infusion. Conclusion-The CCK producing cell is under constant suppression by intraduodenal bile acids which cannot be further enhanced by a physiological bile acid mixture. However, removal of duodenal bile acids by inhibition of gall bladder contraction unmasks this suppression leading to a dramatic increase in plasma CCK levels. As little as one third of postprandially released bile acids completely reverse this effect. Bile acids are the most important luminal regulator of CCK release in humans.
(Gut 1996; 39: 661-667) Keywords : bile acids, bile, pancreatic enzyme secretion, CCK-A receptor antagonist, cholecystokinin, pancreatic polypeptide.
The control mechanisms of the intestinal phase of exocrine pancreatic secretion are complex. Food components interact with digesting factors, such as gastric acid, bile, and pancreatic juice, and eventually come into contact with intestinal epithelial cells and probably sensory nerve endings causing release of hormones and activation of neurones, which in turn regulate exocrine pancreatic secretion.
In humans, one of the most potent local luminal regulators of exocrine pancreatic secretion was found to be bile. However, results differ with respect to the effect of bile and bile acids on basal stimulated exocrine pancreatic secretion. Basal secretion was reported to be enhanced by bilel`whereas stimulated pancreatic secretion was either unaltered4 or inhibited.5 6 The most important hormone involved in the regulation of exocrine pancreatic secretion is cholecystokinin (CCK), which accounts for about 50% of postprandially released pancreatic enzymes.7 8 In addition, CCK is the predominant mediator of gall bladder contraction. Postprandial duodenal bile content is reduced to about 5% of infusion of the highly specific CCK-A receptor antagonist loxiglumide.7 8 Bile acids in turn have been found to inhibit stimulated CCK release.4 9 One crucial point about all the studies investigating the effect of bile acids on either exocrine pancreatic secretion or plasma CCK release is the use of supraphysiological concentrations and amounts of bile acids. Furthermore, in most studies sodium taurocholate and chenodeoxycholic acid were used as single bile acids each accounting for only 150/6-30% of all bile acids secreted.'2 13 Thus, the physiological relevance of luminal bile acids in the regulation of exocrine pancreatic secretion and CCK release is still largely unknown.
The purpose of our study was to provide a near physiological situation by duodenal perfusion of a bile acid mixture mimicking the individual endogenous bile acid composition and concentration of the person under investigation. Endogenous bile acid output was reduced by inhibiting gall bladder contraction by infusion of the highly specific CCK-A receptor antagonist loxiglumide.14 15 We were thereby able to show that duodenal bile acids are of minor importance in the regulation of postprandial pancreatic enzyme secretion but are a key regulator of stimulated CCK release. Bile acids appear to exert a constant inhibitory tone on the intestinal CCK producing cell.
Methods

SUBJECTS
Seven healthy male volunteers aged 22-27 had given informed written consent to participate in this study. The protocol had been approved by the local ethical committee of the Medical Faculty of the Philipps-University of Marburg.
Experimental protocol On the morning after an overnight fast a triplelumen tube was positioned with its tip in the distal part of the duodenum under fluoroscopic guidance. The most proximal lumen ended in the gastric antrum and was used for continuous aspiration of gastric acid. The second lumen terminated in the middle part of the duodenum close to the Papilla of Vateri and served as perfusion site for the recovery marker polyethylene glycol (PEG 4000, dissolved in 0.9% saline) and for the liquid test meal plus PEG with or without bile acids. The perfusion rate was 2 ml/min. Duodenal contents were continuously collected via the third lumen, which was located 10 cm distally to the perfusion site. Samples were obtained at 15 40 g glucose, 300 ml water) over 120 minutes in order to obtain separate control values for the first and second hour. The amount of bile acids released during the first hour of the stimulation period was used to calculate bile acid perfusates on the following days.
Day 2
During the first hour of the stimulation period the liquid test meal was mixed with 30% of bile acid output as determined on day 1. The bile acid mixture comprised all the bile acids identified in the duodenal function from day 1 mixed according to their individual proportions. During the second hour of the stimulation period the test meal was perfused without bile acids. Via an indwelling venous catheter in the forearm, a continuous infusion of saline was given over the whole study time.
Day 3
During the first hour of the stimulation period the liquid test meal was mixed with 100% of the bile acid output determined on day 1. The bile acid mixture comprised all the bile acids identified in the duodenal fraction from day 1 mixed according to their individual proportions. Over the second hour of the stimulation period the test meal was perfused without bile acids. Saline was infused intravenously over the whole experimental period.
Day 4
Duodenal perfusion during the basal and stimulation period was performed according to the conditions on day 2. Instead of saline, however, the CCK-A receptor antagonist loxiglumide was infused intravenously at a rate of 10 mg/h per kg body weight. Infusion of loxiglumide was started at the beginning of the basal period. According to previous measurements maximum steady state plasma concentrations of loxiglumide are achieved after 45-60 minutes of intravenous infusion.7
Days 2 and 4 were performed in random order.
BILE ACID COMPOSITION
The individual bile acid compositions were determined in duodenal aspirates using high pressure liquid chromatography. '6 In three volunteers, the day to day variation in bile acid composition was investigated. Over two weeks no significant variation in bile acid composition was observed. Furthermore, it has been shown by others that day to day variation in bile acid composition is negligible.'3 ENZYME, BIIE ACID, BILIRUBIN, AND PEG
MEASUREMENTS
The volume of gastric and duodenal samples was determined to the closest millilitre and corrected for loss by reference to PEG recovery (see under Calculations and statistics below). The pH was monitored repeatedly during the test and in each 15 ml portion. It did not decrease below 6. Trypsin activity was determined using TAME (p-toluolsulphonyl-l-arginin-methylester) as substrate by the method of Hummel. '7 Amylase and lipase activities and bilirubin and bile acid content were determined by the use of commercially available kits. PEG was measured by turbidimetry using the method of 
Results
Bile acid composition Determination of bile acids in duodenal aspirates showed a wide individual variation (Fig 1) .Glycine conjugates amounted to 79% and taurine conjugates 21% of duodenal bile acids. Glycoursodeoxycholic acid, glycolithocholic acid, tauroursodeoxycholic acid, and taurolithocholic acid were only inconsistently detected in duodenal aspirates.
Bile acid and bilirubin output During test meal perfusion, bile acid output was 4-5 (0 1) mmol during the first hour and this was reduced to 2.1 (0.5) mmol over the second hour (Fig 2A) 1 in a quantity that equalled 30% of the output measured on day 1 during the first hour of stimulation, with saline infused intravenously (iv) (day 2), and a test meal plus an individual bile acid mixture as determined on day 1 in a quantity that equalled 30% of the output measured on day 1 during thefirst hour ofstimulation, with loxiglumide infused iv at a concentration of 10 mg/h per kg; this infusion was started at least 60 minutes before the test meal period and was continued throughout the study.
were significantly higher than during the first hour (p<0 05).
The addition of 30 or 100% of the individual bile acid mixture to the test meal diminished these differences resulting in almost identical enzyme output over both stimulation periods.
Loxiglumide infusion reduced enzyme output by 650/o-75%. In parallel to the test meal perfusion alone, enzyme output was higher during the second hour than during the first hour, irrespective of concomitant perfusion of bile acids (Fig 3) . (Fig 4) . This fourfold increase compared with the preceding hour was significant when calculated as integrated output (p<005 ; Table II ).
PP release Plasma PP concentrations gradually increased during test meal perfusion (Fig 4) . The addition of 30% of bile acids slightly suppressed PP values. Owing to the wide interindividual variations, the differences showed no statistical significance. Loxiglumide almost completely abolished PP release (Table II) .
Discussion
The role of intraduodenal bile acids in the control of basal and postprandial pancreatic enzyme and CCK release remains controversial. A major reason for the diverging results is the use of unphysiologically high concentrations of single bile acids or supraphysiological amounts of bile acids. We therefore used an experimental approach that mimicked physiological postprandial conditions to study the role of intraduodenal bile acids in the control of CCK release and pancreatic enzyme secretion. In order to achieve this, we determined the duodenal bile acid composition and Amylase (kU/h) 20 (4) 29 (6) 14 (2) 21 (5) 24 (1) 20 (1) 4 (1) Time (min) Figure 4 : CCK (A) and PP (B) output during continuous duodenalperfusion of a test meal (day 1), a test meal plus an individual bile acid mixture as determined on day 1 in a quantity that equalled 30% ofthe output measured on day 1 during the first hour of stimulation, with saline infused intravenously (iv) (day 2) , and a test meal plus an individual bile acid mixture as determined on day 1 in a quantity that equalled 30% of the ouput measured on day 1 during the first hour ofstimulation, with loxiglumide infused iv at a concentration of 10 mg/h per kg; this infusion was started at least 60 minutes before the test meal period and was continued throughout the study.
As seen in acute bile diversion induced by external biliary drainage in patients with obstructive jaundice25 or by oral or duodenal application of the bile acid binding resin cholestyramine,9 26 CCK-A receptor blockade, which reduced intraluminal bile acid content to almost zero, substantially stimulated plasma CCK release. This increase in plasma CCK could be diminished to near control values (test meal perfusion alone, intravenous saline) by the addition of only 30% of the individual bile acid mixture to the test meal. This is in agreement with the inhibitory effect of chenodeoxycholic acid on cholestyramine induced CCK stimulation.4 It can be concluded that the presence of one third of the amount of bile acids released during a test meal perfusion is suficient to suppress excess release of CCK.
Our results clearly demonstrate a negative feedback control of CCK release by intraduodenal bile acids. The CCK producing cell is under constant suppression by intraduodenal bile acids which cannot be further enhanced by the addition of a physiological bile acid mixture. However, removal of duodenal bile acids by inhibition of gall bladder contraction unmasks this suppression leading to a dramatic increase in plasma CCK levels, which in turn can be reversed by intraduodenal bile acid application. It remains open whether a threshold of intraduodenal bile acid concentration (or amount) exists at which suppression of CCK release is turned off or whether gradual reduction of bile acids causes a reciprocal rise in plasma CCK levels. Interestingly, during CCK-A receptor blockade, plasma CCK levels rose only when luminal stimuli of CCK release, such as protein or fatty acids, were concomitantly perfused through the duodenum. Basal values were unaffected. It may be speculated that luminal stimuli of CCK act via release of a CCK releasing factor which under physiological postprandial conditions is partly inactivated by intraluminal bile acids. 
